MAZE position history
The shares of Maze Therapeutics (MAZE) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 35,000 shares, $1M, 0.24% of portfolio, New
- 2026 Q2: 65,000 shares, $1.9M, 0.37% of portfolio, Add +85.7%
- 2026 Q3: 65,000 shares, $1.8M, 0.38% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|